ArticleEMBO molecular medicine2026

Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.

Suresh Chava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.